James Hardie Industries Plc - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by James Hardie Industries Plc, a foreign private issuer, for the month of August 2019. The report was signed on August 23, 2019, by Natasha Mercer, Company Secretary. The filing serves primarily to disclose forward-looking statements and specific regulatory exhibits rather than presenting a full set of financial results for a specific quarter or year.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing containing a forward-looking statements disclaimer and an exhibit index, rather than a financial results announcement.
Material Changes
No material changes to financial performance or operations are detailed in this specific filing text. The document references a prior Form 20-F filed on May 21, 2019, and amended on August 8, 2019, for comprehensive risk factor disclosures.
Guidance, Outlook, and Risks
The filing contains an extensive list of forward-looking statements and associated risks. Key areas of uncertainty and potential impact include:
- Asbestos Liabilities: Expectations regarding contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls, and the impact of currency exchange rates on recorded liabilities.
- Legal and Regulatory: Outcomes of legal proceedings, product liability, environmental matters, and compliance with changing tax laws.
- Operational and Strategic: Costs associated with plant closures or capital expenditure projects, integration of Fermacell, and potential changes to credit facilities.
- Economic Conditions: Sensitivity to US and Asia Pacific housing markets, new home construction levels, consumer confidence, interest rates, and currency exchange fluctuations.
- Corporate Actions: Expectations concerning dividend payments and share buy-backs.
The company explicitly states it assumes no obligation to update these forward-looking statements except as required by law.
Investor Verification Checklist
- Review the Form 20-F (filed May 21, 2019, amended August 8, 2019) for detailed "Risk Factors" and financial data.
- Verify the status and funding adequacy of the Asbestos Injuries Compensation Fund (AICF).
- Monitor updates on the integration of the Fermacell acquisition.
- Check for any new material legal proceedings or changes in asbestos-related litigation outcomes.
- Review subsequent filings for actual financial results, as this 6-K does not contain them.